Dutch Bros, SoundHoundAI, Kohl's and Ondas are among the top ten most-heavily shorted stocks in

MiniMed Group Inc (NASDAQ: MMED - Get Free Report)'s share price gapped down before the market opene

Medtronic plc ((Medtronic, NYSE:MDT) today announced that, based on preliminary results, its previou

GALWAY, Ireland, Oct. 12, 2026 /PRNewswire/ -- Medtronic plc (Medtronic; NYSE: MDT) today announced

Big banks kick off third-quarter earnings season tomorrow, and Wall Street analysts are already resh

Jefferies analyst Michael Toomey initiates coverage on Minimed Group (NASDAQ:MMED) with a Hold ra

MiniMed Group Inc (NASDAQ: MMED - Get Free Report) saw unusually large options trading on Friday. Tr

Mizuho analyst Anthony Petrone maintains Minimed Group (NASDAQ:MMED) with a Outperform and raises

Cramer dislikes Rambus and MiniMed, calls GigaCloud highly speculative, sees Babcock & Wilcox as

GALWAY, Ireland, Oct. 7, 2026 /PRNewswire/ -- Medtronic plc (Medtronic; NYSE: MDT) today announced t

Barclays analyst Christopher Pasquale initiates coverage on Minimed Group (NASDAQ:MMED) with a Eq

Shares of MiniMed Group Inc (NASDAQ: MMED - Get Free Report) saw unusually-high trading volume on Mo

MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today presented new clinical evidence

Ten stocks have over 34% of their float short, with ONDS and BROS on the list led by VG.

Truist Securities analyst Richard Newitter initiates coverage on Minimed Group (NASDAQ:MMED) with

MiniMed (NASDAQ:MMED) announced that it has filed a Form S-4 Registration Statement today with the S

Morgan Stanley analyst Kallum Titchmarsh maintains Minimed Group (NASDAQ:MMED) with a Overweight

Citigroup analyst Joanne Wuensch maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the

Evercore ISI Group analyst Daniel Markowitz maintains Minimed Group (NASDAQ:MMED) with a Outperfo

Wells Fargo analyst Larry Biegelsen maintains Minimed Group (NASDAQ:MMED) with a Overweight and r

U.S. stocks rose; Sirius XM jumped 5.5% after Deutsche Bank’s upgrade, while GitLab, Dell and other

MiniMed Group beat Q1 sales estimates with 16.6% growth to $843M; shares rose 7.1% as analysts raise

UBS analyst Patrick Wood maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price ta

Mizuho analyst Anthony Petrone maintains Minimed Group (NASDAQ:MMED) with a Outperform and raises

B of A Securities analyst Travis Steed maintains Minimed Group (NASDAQ:MMED) with a Buy and raise

BTIG analyst Marie Thibault maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price

Gainers bioAffinity Technologies (NASDAQ:BIAF) shares rose 43.1% to $6.53 during Tuesday's regu

On Tuesday, Minimed Group (NASDAQ:MMED) discussed first-quarter financial results during its earning

U.S. stocks were lower, with the Nasdaq Composite falling around 1% on Tuesday. Shares of Yext In

Minimed Group (NASDAQ:MMED) reported quarterly sales of $843.000 million which beat the analyst cons

MiniMed Group, Inc. (MMED) will report Q1 earnings on Sept. 1. Analysts expect 9 cents/share, down f

The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and keton

Wells Fargo analyst Larry Biegelsen maintains Minimed Group (NASDAQ:MMED) with a Overweight and l

Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELY

Minimed Group (NASDAQ:MMED) reported quarterly losses of $(0.68) per share which missed the analyst

Agreement builds on the companies' ongoing partnership to expand choice and simplify diabetes ma

B of A Securities analyst Travis Steed maintains Minimed Group (NASDAQ:MMED) with a Buy and lower

Benchmark analyst Bruce Jackson initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rati

MiniMed Group, Inc. ((MiniMed, NASDAQ:MMED), a global leader in insulin delivery, announced Health C

On April 24, 2026, Medtronic plc ("Medtronic"), the parent company of MiniMed Group, Inc. (&

US stock futures rise, Vicor Corp shares dip 2.2% in pre-market trading after beating earnings and s

Goldman Sachs calls Minimed Group a compelling play on the diabetes market and a potentially profit

MiniMed shows improved pipeline and valuation upside as insulin pump adoption grows despite rising c

Wall Street analysts changed outlook on top stocks. See ratings changes for MTRN, AQN, SXT, MMED, an

Barclays analyst Matt Miksic initiates coverage on Minimed Group (NASDAQ:MMED) with a Overweight

William Blair analyst Steven Lichtman initiates coverage on Minimed Group (NASDAQ:MMED) with a Ou

Citigroup analyst Joanne Wuensch initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rat